These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 8339411

  • 1. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM, Berk MR, Brozena SC, Elkayam U, Plehn JF, Kukin ML, Packer M, Murphy BE, Neuberg GW, Steingart RM.
    Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors.
    Gottlieb SS, Kukin ML, Penn J, Fisher ML, Cines M, Medina N, Yushak M, Taylor M, Packer M.
    J Am Coll Cardiol; 1993 Oct; 22(4):963-7. PubMed ID: 8409070
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A non-invasive evaluation of flosequinan on haemodynamics and exercise capacity in chronic congestive heart failure.
    Motro M, Freimark D, Feinberg MS, Wynne RD, King C, Schneeweiss A.
    Int J Clin Pharmacol Res; 1993 Oct; 13(3):143-9. PubMed ID: 8225697
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the effects of captopril and flosequinan in patients with severe heart failure.
    Cowley AJ, Wynne RD, Swami A, Birkhead J, Skene A, Hampton JR.
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):465-70. PubMed ID: 1450090
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group.
    Littler WA, Sheridan DJ.
    Br Heart J; 1995 May; 73(5):428-33. PubMed ID: 7786657
    [Abstract] [Full Text] [Related]

  • 13. Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the PROFILE Trial After 24 Years.
    Packer M, Pitt B, Rouleau JL, Swedberg K, DeMets DL, Fisher L.
    JACC Heart Fail; 2017 Jun; 5(6):399-407. PubMed ID: 28501522
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
    Gheorghiade M, Hall VB, Jacobsen G, Alam M, Rosman H, Goldstein S.
    Circulation; 1995 Oct 01; 92(7):1801-7. PubMed ID: 7671364
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
    Majumdar SR, McAlister FA, Cree M, Chang WC, Packer M, Armstrong PW, ATLAS Study Group.
    Clin Ther; 2004 May 01; 26(5):694-703. PubMed ID: 15220013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.